Anti GM-2 Monoclonal Antibody

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti GM-2 Monoclonal Antibody, covering 2024-04-25 to 2024-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma [Phase 1]